Fondazione Poliambulanza — Clinical Trial Site

38 Registered trials

21 Currently recruiting

Organisation

Fondazione Poliambulanza

Location

Brescia, Italy

Identifier

ORG-100045991

Address

Via Leonida Bissolati 57, 25124, Italy

Departments

Cardiology
Digestive Endoscopy
Fondazione Poliambulanza Istituto Ospedaliero
Gastroenterology and Digestive Endoscopy Unit
Gastroenterology Complex Operative Unit
medical oncology
Medical Oncology Unit
Oncologia Medica
Oncologico
Oncology
Oncology Unit
Onology Operational Unit
Orthopedics and Traumatology
U.O. Oncologia
U.O. Oncologia Medica
U.O.ONCOLOGIA MEDICA
Unità emodinamica
Unità Operativa di Gastroenterologia ed Endoscopia Digestiva
Unita Operativa Oncologia Medica
UO Gastroenterologia ed Endoscopia Digestiva
UO Gastroentrologia ed Endoscopia Digestiva
UO Oncologia
UO Oncologia Medica

Clinical trials at this site (38)

Search interface

Investigate the efficacy and safety of a bio-marker driven cetuximab-based treatment regimen over 3 treatment lines in mCRC patients with RA… Recruiting

2024-518534-81-00 metastatic colorectal cancer 4 2021-07-01
A Study of Zolbetuximab Together with Pembrolizumab and Chemotherapy in Adults with Gastric Cancer Ended

2024-519773-19-00 Gastroesophageal Junction Adenocarcinoma 5 2025-07-31
A PHASE 1/2 STUDY EXPLORING THE SAFETY AND ACTIVITY OF TRIFLURIDINE/TIPIRACIL IN COMBINATION WITH CAPECITABINE AND BEVACIZUMAB IN METASTATIC… Ended

2024-513271-41-00 colorectal metastatic cancer 4 2024-09-16
Comparison of two strategies that use the same drugs but with inverted sequence for the treatment of patients with metastatic colorectal can… Ended

2024-513296-41-00 Colorectal cancer spread at distance, RAS BRAF wild typ 4 2020-12-03
A Study of Zolbetuximab (IMAB362) in Adults with Pancreatic Cancer Ended

2024-510985-17-00 First Line Treatment in Subjects with Claudin 18.2 (CLD 4 2019-03-14
IRinotecan and Oxaliplatin for Colon Cancer in Adjuvant Setting Ended

2024-517489-41-00 High-risk stage III colon cancer 5 2017-03-27
Use of circulating tumor dna test to intensify post-operative treatment of patients with resected colon cancer. Halted

2024-515152-20-00 Stage III and high-risk stage II resected colon cancer 4 2023-03-02
A phase III, international, multiCenter, randomized, paraLlel-group, Endoscopist-blinded non-inferiority study of the efficAcy, safety and p… Ended

2025-521451-23-00 Subjects scheduled for elective colonoscopy performed a 5 2025-09-03
A study to test whether BI 765845 helps people who have had a heart attack Ended

2022-502788-39-00 acute myocardial infarction 4 2023-11-27
ABTECT-1 – ABX464 Treatment Evaluation for ulcerative Colitis Therapy -1 Ended

2022-500535-36-01 Moderately to severely active ulcerative colitis 5 2023-06-12
Sotorasib and Panitumumab Versus Investigator’s Choice for Subjects with KRAS p.G12C Mutation (CodeBreaK 300) Ended

2024-511187-81-00 Colorectal Cancer (CRC) 5 2022-03-28
Study Comparing Bemarituzumab plus Chemotherapy with Placebo and Chemotherapy in Previously Untreated Advanced Gastric or Gastroesophageal J… Ended

2023-505457-40-00 Previously Untreated Advanced Gastric or Gastroesophage 5 2022-02-02
Multicenter Extension Study of Oral Ozanimod in patients with Moderately to Severely Active Crohn's Disease Ended

2024-511553-22-00 Moderately to Severely Active Crohn's Disease 5 2018-10-05
Multicenter Study of Oral Ozanimod as Maintenance Therapy in patients with Moderately to Severely Active Crohn's Disease Ended

2023-510426-33-00 Moderately to Severely Active Crohn's Disease 5 2018-09-27